CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
113 hedge funds and large institutions have $112M invested in Cymabay Therapeutics in 2019 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 34 increasing their positions, 31 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
41% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 46
66% less capital invested
Capital invested by funds: $328M → $112M (-$216M)
Holders
113
Holding in Top 10
3
Calls
$930K
Puts
$55K
Top Buyers
| 1 | +$9.77M | |
| 2 | +$5.49M | |
| 3 | +$3.93M | |
| 4 |
D.E. Shaw & Co
New York
|
+$2.61M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
+$1.47M |
Top Sellers
| 1 | -$29.2M | |
| 2 | -$16.2M | |
| 3 | -$12M | |
| 4 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
-$10.6M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$9.5M |